TNDM

TNDM

USD

Tandem Diabetes Care Inc. Common Stock

$15.210+0.980 (6.887%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$14.230

Hoch

$15.355

Tief

$14.140

Volumen

0.77M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.0B

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.13M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $9.98Aktuell $15.210Hoch $38.28

Ähnliche Nachrichten

BusinessWire

Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

Certification affirms Tandem's company-wide commitment to cybersecurity, data protection, and operational integrity Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company,

Mehr anzeigen
Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

Mehr anzeigen
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
BusinessWire

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Stifel 2025

Mehr anzeigen
Tandem Diabetes Care Announces Upcoming Conference Presentations
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

Mehr anzeigen
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors ...

Mehr anzeigen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

Analyst Upgrades

Stifel Reinstates Hold on Tandem Diabetes Care, Announces $15 Price Target

Stifel analyst Jonathan Block reinstates Tandem Diabetes Care with a Hold and announces $15 price target.